SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-055625
Filing Date
2009-10-30
Accepted
2009-10-30 16:08:08
Documents
36
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c91609e10vq.htm 10-Q 568636
2 EXHIBIT 31.1 c91609exv31w1.htm EX-31.1 5901
3 EXHIBIT 31.2 c91609exv31w2.htm EX-31.2 5923
4 EXHIBIT 32.1 c91609exv32w1.htm EX-32.1 3087
5 EXHIBIT 32.2 c91609exv32w2.htm EX-32.2 3411
  Complete submission text file 0000950123-09-055625.txt   2298088

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT celg-20090930.xml EX-101.INS 412426
7 EX-101 SCHEMA DOCUMENT celg-20090930.xsd EX-101.SCH 14978
8 EX-101 CALCULATION LINKBASE DOCUMENT celg-20090930_cal.xml EX-101.CAL 43278
9 EX-101 LABELS LINKBASE DOCUMENT celg-20090930_lab.xml EX-101.LAB 157743
10 EX-101 PRESENTATION LINKBASE DOCUMENT celg-20090930_pre.xml EX-101.PRE 91007
11 EX-101 DEFINITION LINKBASE DOCUMENT celg-20090930_def.xml EX-101.DEF 10655
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 0501
Type: 10-Q | Act: 34 | File No.: 000-16132 | Film No.: 091148308
SIC: 2834 Pharmaceutical Preparations